---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-065979"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2025-07-07T23:59:59+00:00"
generated_at: "2026-05-18T09:15:44.172417+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pacira enters $300M revolving credit facility, replaces prior term loan A

## Summary
- $300M senior secured revolver matures July 3, 2030; includes $10M LC sublimit and $15M swingline.
- Proceeds used to repay and terminate existing term loan A facility; no prepayment penalties.
- Interest rates: SOFR + 2.50%-3.25% or base rate + 1.50%-2.25%, based on leverage ratio.
- Facility secured by substantially all assets of Pacira and subsidiary guarantors.
- Incremental facility capacity up to greater of $225M or 100% Consolidated EBITDA.

## SEC filing metadata
- accession: 0001104659-25-065979
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2025-07-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000110465925065979/0001104659-25-065979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000110465925065979/tm2519804d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-065979
- JSON: https://secwatch.observer/filing/0001104659-25-065979.json
- Plain text: https://secwatch.observer/filing/0001104659-25-065979.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.